tradingkey.logo

BIO-Key International Inc

BKYI
查看詳細走勢圖
0.618USD
-0.007-1.10%
收盤 12/24, 13:00美東報價延遲15分鐘
4.52M總市值
虧損本益比TTM

BIO-Key International Inc

0.618
-0.007-1.10%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-1.10%

5天

-3.26%

1月

-25.53%

6月

-26.42%

今年開始到現在

-63.85%

1年

-38.80%

查看詳細走勢圖

TradingKey BIO-Key International Inc股票評分

單位: USD 更新時間: 2025-12-24

操作建議

BIO-Key International Inc當前公司基本面數據相對健康,增長潛力穩定。當前估值合理,在電子設備與零部件行業排名46/58位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價2.00。中期看,股價處於下降通道。近一個月,市場表現非常差,基本面和技術面綜合得分也較低。目前股價在壓力位和支撐位之間,可以做區間波段操作。

BIO-Key International Inc評分

相關信息

行業排名
46 / 58
全市場排名
354 / 4562
所屬行業
電子設備與零部件

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 1 分析師
買入
評級
2.000
目標均價
+160.01%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

BIO-Key International Inc亮點

亮點風險
BIO-key International, Inc. is a provider of workforce and customer identity and access management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication. The Company’s IAM platform enables secure work-from-anywhere for enterprise, education, and government customers using secure multi-factor authentication (MFA). Its products include PortalGuard and PortalGuard Identity-as-a-Service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, MobileAuth mobile phone authentication application for iOS and Android, and quality accessory fingerprint scanner and FIDO-compliant hardware to provide complete solution for identity-innovating customers. Its PortalGuard is a cloud-based identity platform that allows its customers to integrate with any cloud or on-premise SaaS application, service or cloud host, as well as Windows device authentication through a single IAM platform.
業績增長期
公司處於發展階段,最新年度總收入6.93M美元
估值低估
公司最新PB估值0.75,處於3年歷史低位
先鋒集團持倉
明星投資者先鋒集團持倉,最新持倉36.93K股

BIO-Key International Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

BIO-Key International Inc簡介

BIO-key International, Inc. is a provider of workforce and customer identity and access management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication. The Company’s IAM platform enables secure work-from-anywhere for enterprise, education, and government customers using secure multi-factor authentication (MFA). Its products include PortalGuard and PortalGuard Identity-as-a-Service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, MobileAuth mobile phone authentication application for iOS and Android, and quality accessory fingerprint scanner and FIDO-compliant hardware to provide complete solution for identity-innovating customers. Its PortalGuard is a cloud-based identity platform that allows its customers to integrate with any cloud or on-premise SaaS application, service or cloud host, as well as Windows device authentication through a single IAM platform.
公司代碼BKYI
公司BIO-Key International Inc
CEODepasquale (Michael W)
網址https://www.bio-key.com/

常見問題

BIO-Key International Inc(BKYI)的當前股價是多少?

BIO-Key International Inc(BKYI)的當前股價是 0.618。

BIO-Key International Inc 的股票代碼是什麼?

BIO-Key International Inc的股票代碼是BKYI。

BIO-Key International Inc股票的52週最高點是多少?

BIO-Key International Inc股票的52週最高點是3.680。

BIO-Key International Inc股票的52週最低點是多少?

BIO-Key International Inc股票的52週最低點是0.613。

BIO-Key International Inc的市值是多少?

BIO-Key International Inc的市值是4.52M。

BIO-Key International Inc的淨利潤是多少?

BIO-Key International Inc的淨利潤為-4.30M。

現在BIO-Key International Inc(BKYI)的股票是買入、持有還是賣出?

根據分析師評級,BIO-Key International Inc(BKYI)的總體評級為買入,目標價格為2.000。

BIO-Key International Inc(BKYI)股票的每股收益(EPS TTM)是多少

BIO-Key International Inc(BKYI)股票的每股收益(EPS TTM)是-0.898。
KeyAI